Nuevolution start trading of its shares on Nasdaq Stockholm main market

June 25, 2018
Nuevolution-Logo-and-Name (1)

 

Stockholm, 25 June 2018 @ 09:00:00. “Tio, nio, åtta … tre, två, ett”, in this very moment, and with the sound of the bell, Nuevolution AB (publ) opened the financial markets in Stockholm and started trading of its shares (ticker: NUE) on Nasdaq Stockholm main market.

To read the full press release, please visit the company website.


About Nuevolution
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and programs with pharmaceutical and biotechnology companies to seek future benefit of patients in need of novel medical treatment option. Nuevolution’s internal programs are focused on therapeutically important targets within inflammation, oncology and immuno-oncology.

By continuing to interact with the site, you agree to the use of cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close